Business · 04/09/2018Updated: 10/17/2026 · 1 min read
FDA Renews Cardiovascular and Renal Drugs Advisory Committee for 2 Years
Summary
The Food and Drug Administration (FDA) has announced the renewal of the Cardiovascular and Renal Drugs Advisory Committee, which will run for an additional 2 years beyond its original expiration date, until August 27, 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →